VIR
Vir Biotechnology·NASDAQ
--
--(--)
--
--(--)
7.04 / 10
Outperform
Analyst consensus is strongly bullish: 40% Strong Buy, 60% Buy across five analysts, with historical win rates up to 75%. Fund‑flow score is 7.83 (good), showing overall positive inflows except a slight medium‑size outflow. Sentiment rating is Outperform (7.04).
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
40%
Buy
60%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-24
InstitutionEvercore ISI Group
Times predicted2
Historical Win Rate50.0%
What is the analyst consensus for VIR?
- VIR holds a Bullish analyst rating, with 60% of experts assigning a Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.04/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
